- Record: found
- Abstract: not found
- Article: not found
In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium
D.J.A. Lobbezoo ,
R.J.W. van Kampen ,
A.C. Voogd ,
M.W. Dercksen ,
F. van den Berkmortel ,
T.J. Smilde ,
A.J. van de Wouw ,
F.P.J. Peters ,
J.M.G.H. van Riel ,
N.A.J.B. Peters ,
M. de Boer ,
P.G.M. Peer ,
V.C.G. Tjan-Heijnen
February 2016
February 2016
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The objective of this study was to present initial systemic treatment choices and
the outcome of hormone receptor-positive (HR+) metastatic breast cancer.